^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CYAD-02

i
Other names: CYAD-02
Associations
Trials
Company:
Celyad Oncology
Drug class:
NKG2DL-targeted CAR-T immunotherapy
Associations
Trials